EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lung Cancer in Renal Transplant Recipients

Mirela Jozicic, Alen Imsirovic, Lea Katalinic, Branimir Krtalic, Nikolina Basic Jukic

BANTAO Journal · 2016

DOI: 10.1515/bj-2016-0004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BANTAO Journal, 2016. Verfasst von Mirela Jozicic und 4 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although the incidence of malignancy has increased after solid organ transplantation, data on lung cancer in this group of patients is scarce. The aim of this study was to determine clinical characteristics and outcome of patients who developed lung cancer after renal transplantation.

Methods

Among a cohort of 1658 patients who received a transplant at our institution and were followedup between 1973 and 2014, five patients developed lung cancer. We analyzed risk factors, transplantation characteristics, treatment options and survival.

Results

Lung cancer was diagnosed in 5 patients (0.3%). Time to diagnosis after the transplant procedure ranged from 26 to 156 months (mean 115 months). All of them had a smoking history. Tumors were classified as IIB (20%), IIIA (40%), and IV (40%). Histological types included adenocarcinoma (80%) and there was one case of sarcomatoid carcinoma (20%). One patient had concomitant thyroid papillary carcinoma. Radiotherapy was applied in 2 patients, 2 underwent chemotherapy (erlotinib and combination of carboplatinum and etopozide in one patient each), and 2 died within one month after the diagnosis from disseminated malignant disease. Patients with stage IIIA survived 14 and 24 months after the diagnosis. The patient with sarcomatoid cancer underwent thoracotomy with a complete resection, lost his graft function and died 7 months after the diagnosis.

Conclusion

Lung cancer is relatively rare malignancy in renal transplant recipients, but associated with high mortality. Smoking is a significant risk factor, thus smoking cessation should be promoted among renal transplant recipients, as well as regular screening for lung cancer.

Zitieren

APA

Jozicic, M., Imsirovic, A., Katalinic, L., Krtalic, B., & Jukic, N. B. (2016). Lung Cancer in Renal Transplant Recipients. BANTAO Journal. https://doi.org/10.1515/bj-2016-0004

Vancouver

Jozicic M, Imsirovic A, Katalinic L, Krtalic B, Jukic NB. Lung Cancer in Renal Transplant Recipients. BANTAO Journal. 2016. doi:10.1515/bj-2016-0004

BibTeX
@article{Jozicic2016,
  author = {Jozicic, Mirela and Imsirovic, Alen and Katalinic, Lea and Krtalic, Branimir and Jukic, Nikolina Basic},
  title = {Lung Cancer in Renal Transplant Recipients},
  journal = {BANTAO Journal},
  year = {2016},
  doi = {10.1515/bj-2016-0004}
}
Kostenlos starten →